Stewart RH - Search Results

1

Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate.

Stewart RH, Smith JP, Rosenthal AL. Stewart RH, et al. Curr Eye Res. 1984 Jun;3(6):835-9. doi: 10.3109/02713688409000796. Curr Eye Res. 1984. PMID: 6375979 Clinical Trial.

2

Norepinephrine dipivalylate dose-response in ocular hypertensive subjects.

Stewart RH, Kimbrough RL, Martin PA, Ward RL, Smith JP 3rd. Stewart RH, et al. Ann Ophthalmol. 1981 Nov;13(11):1279-83. Ann Ophthalmol. 1981. PMID: 7034617 Clinical Trial.

3

Use of steroid/antibiotic prophylaxis in intraocular lens implantation: a double-masked study v placebo.

Stewart RH, Kimbrough RL, Smith JP, deFaller JM. Stewart RH, et al. Ann Ophthalmol. 1983 Jan;15(1):24-8. Ann Ophthalmol. 1983. PMID: 6299159 Clinical Trial.

4

Effects of beta-aminopropionitrile after glaucoma filtration surgery: pilot human trial.

Moorhead LC, Smith J, Stewart R, Kimbrough R. Moorhead LC, et al. Ann Ophthalmol. 1987 Jun;19(6):223-5. Ann Ophthalmol. 1987. PMID: 3619271

5

Intraocular pressure response to topically administered fluorometholone.

Stewart RH, Kimbrough RL. Stewart RH, et al. Arch Ophthalmol. 1979 Nov;97(11):2139-40. doi: 10.1001/archopht.1979.01020020457010. Arch Ophthalmol. 1979. PMID: 508182

6

Evaluation of dexamethasone acetate as a topical ophthalmic formulation.

Leibowitz HM, Kupferman A, Stewart RH, Kimbrough RL. Leibowitz HM, et al. Among authors: stewart rh. Am J Ophthalmol. 1978 Sep;86(3):418-23. doi: 10.1016/0002-9394(78)90249-0. Am J Ophthalmol. 1978. PMID: 717508

7

ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery.

Brown RH, Stewart RH, Lynch MG, Crandall AS, Mandell AI, Wilensky JT, Schwartz AL, Gaasterland DE, DeFaller JM, Higginbotham EJ. Brown RH, et al. Among authors: stewart rh. Ophthalmology. 1988 Mar;95(3):378-84. doi: 10.1016/s0161-6420(88)33185-4. Ophthalmology. 1988. PMID: 3050686 Clinical Trial.

8

A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution.

Weinreb RN, Caldwell DR, Goode SM, Horwitz BL, Laibovitz R, Shrader CE, Stewart RH, Williams AT. Weinreb RN, et al. Among authors: stewart rh. Am J Ophthalmol. 1990 Aug 15;110(2):189-92. doi: 10.1016/s0002-9394(14)76990-9. Am J Ophthalmol. 1990. PMID: 2198812 Clinical Trial.

9

Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine.

Pollack IP, Brown RH, Crandall AS, Robin AL, Stewart RH, White GL. Pollack IP, et al. Among authors: stewart rh. Arch Ophthalmol. 1988 Jun;106(6):754-7. doi: 10.1001/archopht.1988.01060130824031. Arch Ophthalmol. 1988. PMID: 3369999 Clinical Trial.

10

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

Stewart WC, Laibovitz R, Horwitz B, Stewart RH, Ritch R, Kottler M. Stewart WC, et al. Among authors: stewart rh. Arch Ophthalmol. 1996 Aug;114(8):938-42. doi: 10.1001/archopht.1996.01100140146006. Arch Ophthalmol. 1996. PMID: 8694728 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters